Literature DB >> 33603669

Inonotus obliquus Polysaccharide Ameliorates Azoxymethane/Dextran Sulfate Sodium-Induced Colitis-Associated Cancer in Mice via Activation of the NLRP3 Inflammasome.

Jiawei Li1, Chao Qu1, Fangfang Li1, Yifang Chen1, Jinjuan Zheng1, Yao Xiao1, Quanxin Jin1, Guihua Jin1, Xuezhu Huang2, Dan Jin1.   

Abstract

Inonotus obliquus polysaccharide (IOP), the primary constituent of the parasitic fungus Inonotus obliquus, has anti-tumor, anti-inflammatory, anti-oxidation effects. However, the roles of IOP on colitis-associated cancer (CAC) are still unclear. Herein, we tested the efficacy of IOP using a mouse model of CAC induced by azoxymethane and dextran sulfate sodium (AOM/DSS). We confirmed that intragastric administration of IOP decreased CAC-induced body weight loss, colon tissue damage, colon shortening, and expression of proinflammatory mediators. Meanwhile, IOP treatment increased in expression of the NLRP3 inflammasome, IL-1β, and IL-18 in the colon of CAC mice. Moreover, in vitro, IOP inhibited the proliferation of SW620 colorectal cancer cells. Finally, overexpression of NLRP3 with plasmid transfection could further enhance the activation of NLRP3 inflammasome by IOP. Taken together, these results suggest that IOP suppresses the development of CAC, possibly by activation of the NLRP3 inflammasome, and reveal that IOP may be a therapeutic drug candidate for CAC.
Copyright © 2021 Li, Qu, Li, Chen, Zheng, Xiao, Jin, Jin, Huang and Jin.

Entities:  

Keywords:  AOM/DSS; CAC; NLRP3 inflammasome; inonotus obliquus polysaccharide; proinflammatory mediators

Year:  2021        PMID: 33603669      PMCID: PMC7884887          DOI: 10.3389/fphar.2020.621835

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  29 in total

1.  Targeted agents for adjuvant therapy of colon cancer.

Authors:  Mohammad Wasif Saif
Journal:  Clin Colorectal Cancer       Date:  2006-05       Impact factor: 4.481

2.  NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis.

Authors:  Simon A Hirota; Jeffrey Ng; Alan Lueng; Maitham Khajah; Ken Parhar; Yan Li; Victor Lam; Mireille S Potentier; Kelvin Ng; Misha Bawa; Donna-Marie McCafferty; Kevin P Rioux; Subrata Ghosh; Ramnik J Xavier; Sean P Colgan; Jurg Tschopp; Daniel Muruve; Justin A MacDonald; Paul L Beck
Journal:  Inflamm Bowel Dis       Date:  2010-09-24       Impact factor: 5.325

3.  Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome.

Authors:  Christian Bauer; Peter Duewell; Christine Mayer; Hans Anton Lehr; Katherine A Fitzgerald; Marc Dauer; Jurg Tschopp; Stefan Endres; Eicke Latz; Max Schnurr
Journal:  Gut       Date:  2010-05-04       Impact factor: 23.059

4.  Neutralization of IL-6 and TNF-α ameliorates intestinal permeability in DSS-induced colitis.

Authors:  Yong-Tao Xiao; Wei-Hui Yan; Yi Cao; Jun-Kai Yan; Wei Cai
Journal:  Cytokine       Date:  2016-05-06       Impact factor: 3.861

5.  The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.

Authors:  Yuichi Yoshida; I-Ching Wang; Helena M Yoder; Nicholas O Davidson; Robert H Costa
Journal:  Gastroenterology       Date:  2007-01-25       Impact factor: 22.682

6.  Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer.

Authors:  Jonas Ungerbäck; Dimitri Belenki; Aksa Jawad ul-Hassan; Mats Fredrikson; Karin Fransén; Nils Elander; Deepti Verma; Peter Söderkvist
Journal:  Carcinogenesis       Date:  2012-07-28       Impact factor: 4.944

7.  Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease.

Authors:  Michael Due Larsen; Niels Qvist; Jan Nielsen; Jens Kjeldsen; Rasmus Gaardskær Nielsen; Bente Mertz Nørgård
Journal:  J Crohns Colitis       Date:  2016-01-22       Impact factor: 9.071

8.  Inhibitory effects of a polysaccharide extract from the Chaga medicinal mushroom, Inonotus obliquus (higher Basidiomycetes), on the proliferation of human neurogliocytoma cells.

Authors:  Xianbin Ning; Qi Luo; Chuang Li; Zhaoyi Ding; Jinfeng Pang; Changfu Zhao
Journal:  Int J Med Mushrooms       Date:  2014       Impact factor: 1.921

9.  Inonotus obliquus polysaccharides induces apoptosis of lung cancer cells and alters energy metabolism via the LKB1/AMPK axis.

Authors:  Shuping Jiang; Fuli Shi; Hui Lin; Ying Ying; Lingyu Luo; Deqiang Huang; Zhijun Luo
Journal:  Int J Biol Macromol       Date:  2019-11-18       Impact factor: 6.953

10.  Pretreatment with a Heat-Killed Probiotic Modulates the NLRP3 Inflammasome and Attenuates Colitis-Associated Colorectal Cancer in Mice.

Authors:  I-Che Chung; Chun-Nan OuYang; Sheng-Ning Yuan; Hsin-Chung Lin; Kuo-Yang Huang; Pao-Shu Wu; Chia-Yuan Liu; Kuen-Jou Tsai; Lai-Keng Loi; Yu-Jen Chen; An-Ko Chung; David M Ojcius; Yu-Sun Chang; Lih-Chyang Chen
Journal:  Nutrients       Date:  2019-02-28       Impact factor: 5.717

View more
  3 in total

1.  Open Reading Frame-3a gene of the 2019 novel coronavirus inhibits the occurrence and development of colorectal cancer.

Authors:  Yang Xi; Wu Wei; Han Shuwen; Wu Yinhang; Mao Jing; Chen Gong; Hou Xiaohui
Journal:  Discov Oncol       Date:  2022-03-20

2.  In Vitro Immunomodulatory Effects of Inonotus obliquus Extracts on Resting M0 Macrophages and LPS-Induced M1 Macrophages.

Authors:  Dayue Shen; Yating Feng; Xilan Zhang; Jing Liu; Le Gong; Hui Liao; Rongshan Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-21       Impact factor: 2.650

3.  Evaluation of Toxicity and Efficacy of Inotodiol as an Anti-Inflammatory Agent Using Animal Model.

Authors:  Thi Minh Nguyet Nguyen; So-Young Ban; Kyu-Been Park; Chang-Kyu Lee; Seoung-Woo Lee; Young-Jin Lee; Su-Min Baek; Jin-Kyu Park; My Tuyen Thi Nguyen; Jaehan Kim; Jihyun Park; Jong-Tae Park
Journal:  Molecules       Date:  2022-07-23       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.